Crescent Biopharma, Inc. (CBIO) vs Bright Minds Biosciences Inc. (DRUG)

Crescent Biopharma, Inc. and Bright Minds Biosciences Inc. are both Biotechnology companies. Crescent Biopharma, Inc. and Bright Minds Biosciences Inc. are of similar size ($528.9M and $527.8M). Across the 9 metrics below, Bright Minds Biosciences Inc. leads on 6 and Crescent Biopharma, Inc. on 3.

Valuation

Metric CBIO DRUG Biotechnology median
P/E n/m n/m 7.88
P/S 350.63 n/m 11.47
P/B 2.68 2.32 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 240.54 n/m 10.73
Earnings yield (48.03%) (3.96%) (28.84%)
Free cash flow yield (16.82%) (3.44%) (23.03%)

Profitability

Metric CBIO DRUG Biotechnology median
Gross margin 19.72% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (112.14%) (13.64%) (57.72%)
Return on assets (97.08%) (13.52%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CBIO DRUG Biotechnology median
Revenue growth (TTM) (45.09%) — 5.64%
EPS growth (last fiscal year) 44.97% (164.58%) —
Revenue growth, 5-year CAGR 257.77% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CBIO DRUG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.66 121.98 4.73
Net debt to EBITDA 1.40 5.98 0.96

Dividend

Metric CBIO DRUG Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CBIO DRUG Biotechnology median
Market cap 528.93m 527.83m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack